Bacteriological follow-up of pulmonary tuberculosis treatment: A study with a simple colorimetric assay

Microbes and Infection

Volumn 6, Issue 11, 2004, Pages 972-976

  Farnia, Parissa ^a   Mohammadi, Foroozan ^a   Mirsaedi, Mehdi ^a   Zia Zarifi, Abolhasan ^a   Tabatabee, Javad ^a   Bahadori, Moslem ^a   Akbar Velayati, Ali ^a   Reza Masjedi, Mohammad ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

AFB viability; Alamar Blue; Malachite Green

Indexed keywords

ALAMAR BLUE; DYE; ETHAMBUTOL; ISONIAZID; MALACHITE GREEN; PYRAZINAMIDE; RIFAMPICIN; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; BACTERIAL GROWTH; BACTERIOLOGY; COLOR; COLORIMETRY; CONTROLLED STUDY; CULTURE MEDIUM; FOLLOW UP; HUMAN; INOCULATION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MICROSCOPY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; SMEAR; SPUTUM ANALYSIS; TIME;

ANTITUBERCULAR AGENTS; BACTERIOLOGICAL TECHNIQUES; COLORIMETRY; FOLLOW-UP STUDIES; HUMANS; MICROSCOPY; MYCOBACTERIUM TUBERCULOSIS; OXAZINES; OXIDATION-REDUCTION; ROSANILINE DYES; SENSITIVITY AND SPECIFICITY; SPUTUM; TIME FACTORS; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; XANTHENES;

MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; SIPROETA STELENES;

EID: 4444339442     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2004.04.017     Document Type: Article

References (21)

1. American Thoracic Society Treatment of tuberculosis and tuberculosis infection in adults and children Am. J. Respir. Crit. Care Med. 149 1994 1359 1374
2. Feng Zang Z., Levy M.H., and Sumin W. Sputum microscopy results at two and three months predict outcome of TB treatment Int. J. Tuberc. Lung Dis. 1 1997 570 572
3. Kim T.C., Blackman R.S., Heatwole K.M., and Rochester D.F. Acid-fast bacilli in sputum smears of patients with pulmonary TB prevalence and significance of negative smears pretreatment and positive smears post treatment Am. Rev. Respir. Dis. 129 1984 264 268
4. Ramarokoto H., Randriamiharisoa A., Rakotoarisaonina T., Rasolovavalona T., Rasolofo V., and Chanteau S. Bacteriological follow-up of tuberculosis treatment: a comparative study of smear microscopy and culture results at the second month of treatment Int. J. Tubercle Lung Dis. 10 2002 909 912
5. Reider H.L. Sputum smears conversion during directly observed treatment for tuberculosis Tubercle Lung Dis. 77 1996 124 129
6. Vidal R., Martin-Casabona N., and Juan A. Incidence and significance of acid-fast bacilli in sputum smears at the end of anti tuberculosis treatment Chest 109 1996 1562 1565
7. Hellyer T.J., Des Jardin L.E., Hehman G.L., Cave M.D., and Elsenach K.D. Quantitative analysis of mRNA as a marker for viability of Mycobacterium tuberculosis J. Clin. Microbiol. 37 1999 290 295
8. 11 media for recovery of Mycobacteria in clinical specimens J. Clin. Microbiol. 37 1999 1366 1369
9. Thomsen V.Q., Jensen A.K., Buser M., Schulz S.P., and Burkardt H.J. Monitoring treatment of patients with pulmonary tuberculosis; can PCR be applied J. Clin. Microbiol. 37 1999 3601 3607
10. DeCock K.M., and Wilkinson D. Tuberculosis control in resource - poor countries; alternative approaches of HIV Lancet 346 1995 675 677
11. Enarson D.A., Rieder H.L., and Arnadottir T. Tuberculosis Guide for Low Income Countries third ed 1994 International Union Against Tuberculosis and Lung Diseases, France Paris
12. Rieder H.L., Chonde T.M., and Myking H. The Public Health Service National Tuberculosis Reference Laboratory and the National Laboratory Network; Minimum Requirements, Role and Operation in Low-income Country 1998 International Union Against Tuberculosis and Lung Diseases Paris
13. Yajko D.M., Madej J.J., Lancaster M.V., Sanders C.A., Cawthon V.L., Gee B., Babst A., and Hadley W.H. Colorimetric method for determining MICs of antimicrobial agents for MTB J. Clin. Microbiol. 33 1995 2324 2327
14. Bastian I., Rigouts L., Palomino J.C., and Portaels F. Kanamycin susceptibility testing of MTB using Mycobacterium Growth Indicator Tube and a colorimetric method Antimicrob. Agents Chemother. 45 2001 1934 1940
15. Pracharktam R., AngkananukooI K., and Vibhagool A. In vitro susceptibility testing of levofloxacin and ofloxacin by microtiter plate Alamar Blue against MDR and non-MDR resistant M. tuberculosis in Thailand J. Med. Assoc. Thailand 84 2001 1241 1245
16. Sungkanuparph S., Pracharktam R., Thankkinstian A., Buabut B., and Kiatatachasaia W. Correlation between susceptibility of MTB by micro titer plate Alamar Blue assay and clinical outcome J. Med. Assoc. Thailand 85 2002 820 824
17. Kent P.T., and Kubica G.P. Public Health Mycobacteriology: a Guide for the Level III Laboratory 1985 US Department of Health and Human Services, Centers for Diseases Control Atlanta, GA
18. Franzblau S.G., Witzig R.S., McLaughlin J.C., Torres P., Madico G., Hernandez A., Degnan M.T., Cook M.B., Quenzer V.K., Ferguson R.M., and Gilman R.H. Rapid, low-technology MIC determination with clinical MTB by using micro plate Alamar Blue Assay J. Clin. Microbiol. 36 1998 362 366
19. Bruchfeld J., Aderage G., Palme I.B., Bjorvatn B., Kallenius G., and Lindquist L. Sputum concentration improves diagnosis of TB in a setting with a high prevalence of HIV Trans. R. Soc. Trop. Med. Hyg. 94 2000 677 680
20. Salaniponi F.M.L., Christensen J.J., Gausi F., Kwanjana J.J., and Harries A.D. Sputum smear status at two months and subsequent treatment outcome in new patients with smear positive pulmonary TB Int. J. Tubercle Lung Dis. 3 1999 1047 1049
21. Al Moamary S.M., Black W., Bessuille E., Elwood K., and Vedal S. The significance of the persistent presence of acid-fast bacilli in sputum smears in pulmonary tuberculosis Chest 116 1999 726 731